1 Kossai M,Leary A,Scoazec JY,et al.Ovarian cancer:a heterogeneous disease[J].Pathobiology,2018,85(1/2):41-49. 2 Ghoneum A,Afify H,Salih Z,et al.Role of tumor microenvironment in ovarian cancer pathobiology[J].Oncotarget,2018,9(32):22832-22849. 3 宋玲,付琼.紫云英苷通过抑制HIF-1α诱导的糖酵解途径发挥抗卵巢肿细胞作用的研究[J].实用肿瘤学杂志,2018,32(6):503-509. 4 Nunes SC,Lopes-Coelho F,Gouveia-Fernandes S,et al.Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions,favouring carboplatin resistance in ovarian cancer[J].BMC Evol Biol,2018,18(1):97. 5 Liu T,Zhao L,Hou H,et al.Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals[J].Tumour Biol,2017,39(5):1393397439. 6 Warfel NA,El-Deiry WS.HIF-1 signaling in drug resistance to chemotherapy[J].Curr Med Chem,2014,21(26):3021-3028. 7 Chen M,Cai F,Zha D,et al.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-small ka,CyrillicB pathway[J].Oncotarget,2017,8(16):26941-26958. 8 Li W,Hao J,Zhang L,et al.Astragalin reduces hexokinase 2 through increasing miR-125b to inhibit the proliferation of hepatocellular carcinoma cells in vitro and in vivo[J].J Agric Food Chem,2017,65(29):5961-5972. 9 Liao J,Qian F,Tchabo N,et al.Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation,metastasis and chemotherapy resistance through hypoxia-resistant metabolism[J].PLoS One,2014,9(1):e84941. 10 Ai Z,Lu Y,Qiu S,et al.Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism[J].Cancer Lett,2016,373(1):36-44. 11 Wang WJ,Sui H,Qi C,et al.Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1alpha in vitro[J].Oncol Rep,2016,36(1):428-440. |